The Canadian lipid guidelines are difficult to model quantitatively.
Holmes
Daniel T
DT
Frohlich
Jiri J
JJ
D003324:Coronary Artery Disease / Q000401:mortality / Q000517:prevention & control*; D050171:Dyslipidemias / Q000188:drug therapy* / Q000401:mortality; D015438:Health Behavior; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008019:Life Style; D015233:Models, Statistical; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D016540:Smoking Cessation; D016896:Treatment Outcome
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors